Celltheon has been developing Cell Engineering technologies since 2012. Celltheon has patents, granted and pending, for its CHOK-1 derived SUPERCELL™ cell line and its unique DNA and RNA vector elements that are applicable for recombinant biotherapeutics such as Mabs, Difficult to Express Proteins (DEP) as well as for CAR-T, Gene Therapy, and Cell Factories applications.

Biotechnology

Celltheon

Amita Goel

Carlos Garcia

Anurag Goel

Nikhil Goel

Nicy Varghese

Divya Goel

Celltheon's Leadership Team includes Divya Goel and 1 others.

About

People

Amita Goel

Divya Goel